Winslow Evans & Crocker Inc. cut its stake in shares of Laboratory Corporation of America Holdings (NYSE:LH) by 6.9% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 7,174 shares of the medical research company’s stock after selling 529 shares during the period. Winslow Evans & Crocker Inc.’s holdings in Laboratory Corporation of America Holdings were worth $1,083,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Rockefeller Financial Services Inc. lifted its position in Laboratory Corporation of America Holdings by 1,494.8% during the third quarter. Rockefeller Financial Services Inc. now owns 2,137 shares of the medical research company’s stock valued at $323,000 after purchasing an additional 2,003 shares in the last quarter. Fisher Asset Management LLC purchased a new position in shares of Laboratory Corporation of America Holdings in the third quarter valued at about $9,888,000. P.R. Herzig & Co. Inc. purchased a new position in shares of Laboratory Corporation of America Holdings in the third quarter valued at about $226,000. Robeco Institutional Asset Management B.V. lifted its position in shares of Laboratory Corporation of America Holdings by 13.0% in the third quarter. Robeco Institutional Asset Management B.V. now owns 16,319 shares of the medical research company’s stock valued at $2,464,000 after acquiring an additional 1,880 shares in the last quarter. Finally, Assenagon Asset Management S.A. purchased a new position in shares of Laboratory Corporation of America Holdings in the third quarter valued at about $8,684,000. Institutional investors own 92.97% of the company’s stock.

In other Laboratory Corporation of America Holdings news, insider Lisa J. Uthgenannt sold 5,000 shares of Laboratory Corporation of America Holdings stock in a transaction on Tuesday, August 1st. The shares were sold at an average price of $160.00, for a total value of $800,000.00. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO David P. King sold 44,687 shares of Laboratory Corporation of America Holdings stock in a transaction on Wednesday, September 6th. The shares were sold at an average price of $156.86, for a total transaction of $7,009,602.82. Following the completion of the transaction, the chief executive officer now owns 258,753 shares in the company, valued at $40,587,995.58. The disclosure for this sale can be found here. Over the last three months, insiders sold 222,968 shares of company stock valued at $34,980,922. 0.90% of the stock is owned by corporate insiders.

TRADEMARK VIOLATION WARNING: This piece was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://www.thecerbatgem.com/2017/10/23/winslow-evans-crocker-inc-has-1-08-million-position-in-laboratory-corporation-of-america-holdings-lh.html.

Several brokerages have recently commented on LH. Craig Hallum restated a “buy” rating and issued a $179.00 price objective (up from $157.00) on shares of Laboratory Corporation of America Holdings in a research report on Thursday, July 27th. Zacks Investment Research upgraded Laboratory Corporation of America Holdings from a “sell” rating to a “hold” rating in a research report on Thursday, July 27th. Barclays PLC boosted their price objective on Laboratory Corporation of America Holdings from $182.00 to $183.00 and gave the company an “overweight” rating in a research report on Thursday, July 27th. Jefferies Group LLC restated a “hold” rating and issued a $170.00 price objective (up from $157.00) on shares of Laboratory Corporation of America Holdings in a research report on Wednesday, September 13th. Finally, ValuEngine upgraded Laboratory Corporation of America Holdings from a “hold” rating to a “buy” rating in a research report on Wednesday, September 6th. Six research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. Laboratory Corporation of America Holdings has a consensus rating of “Buy” and an average target price of $170.31.

Shares of Laboratory Corporation of America Holdings (LH) traded up 0.01% during trading on Monday, hitting $151.74. The stock had a trading volume of 155,609 shares. The stock’s 50 day moving average price is $152.76 and its 200-day moving average price is $149.09. The stock has a market cap of $15.45 billion, a P/E ratio of 21.25 and a beta of 0.92. Laboratory Corporation of America Holdings has a one year low of $119.51 and a one year high of $164.22.

Laboratory Corporation of America Holdings (NYSE:LH) last announced its quarterly earnings results on Wednesday, July 26th. The medical research company reported $2.47 earnings per share for the quarter, beating analysts’ consensus estimates of $2.40 by $0.07. Laboratory Corporation of America Holdings had a net margin of 7.57% and a return on equity of 16.85%. The firm had revenue of $2.50 billion during the quarter, compared to analysts’ expectations of $2.47 billion. During the same period in the previous year, the company earned $2.36 earnings per share. Laboratory Corporation of America Holdings’s quarterly revenue was up 4.9% compared to the same quarter last year. Analysts expect that Laboratory Corporation of America Holdings will post $9.51 earnings per share for the current fiscal year.

Laboratory Corporation of America Holdings Profile

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD).

Institutional Ownership by Quarter for Laboratory Corporation of America Holdings (NYSE:LH)

Receive News & Stock Ratings for Laboratory Corporation of America Holdings Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Corporation of America Holdings and related stocks with our FREE daily email newsletter.